Inflammatory bowel disease and pregnancy: Overlapping pathways

Translational Research

Volumn 160, Issue 1, 2012, Pages 65-83

  Nasef, Noha Ahmed ^a   Ferguson, Lynnette R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOOXYGENASE 2; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 26; INTERLEUKIN 6; MESALAZINE; METRONIDAZOLE; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PREDNISOLONE; PROSTAGLANDIN E2; SALAZOSULFAPYRIDINE; TACROLIMUS; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

BIOLOGICAL THERAPY; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENTERITIS; HELPER CELL; HUMAN; IMMUNE SYSTEM; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH2 CELL;

EID: 84862004167     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.12.002     Document Type: Review

References (255)

1. P.G. Andres, and L.S. Friedman Epidemiology and the natural course of inflammatory bowel disease Gastroenterol Clin North Am 28 1999 255 281 vii
2. J. Cornish, E. Tan, and J. Teare A meta-analysis on the influence of inflammatory bowel disease on pregnancy Gut 56 2007 830 837
3. H.C. Lin, C.C. Chiu, S.F. Chen, H.Y. Lou, W.T. Chiu, and Y.H. Chen Ulcerative colitis and pregnancy outcomes in an Asian population Am J Gastroenterol 105 2010 387 394
4. U. Mahadevan, W.J. Sandborn, D.K. Li, S. Hakimian, S. Kane, and D.A. Corley Pregnancy outcomes in women with inflammatory bowel disease: A large community-based study from Northern California Gastroenterology 133 2007 1106 1112
5. M. Morales, T. Berney, A. Jenny, P. Morel, and P. Extermann Crohn's disease as a risk factor for the outcome of pregnancy Hepato-Gastroenterol 47 2000 1595 1598
6. M.C. Bush, S. Patel, R.H. Lapinski, and J.L. Stone Perinatal outcomes in inflammatory bowel disease J Matern Fetal Neonatal Med 15 2004 237 241
7. M. Hudson, G. Flett, T.S. Sinclair, P.W. Brunt, A. Templeton, and N.A. Mowat Fertility and pregnancy in inflammatory bowel disease Int J Gynaecol Obstet 58 1997 229 237
8. R. Khosla, C.P. Willoughby, and D.P. Jewell Crohns disease and pregnancy Gut 25 1984 52 56
9. K.O. Olsen, S. Juul, I. Berndtsson, T. Oresland, and S. Laurberg Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample Gastroenterology 122 2002 15 19
10. A. Waljee, J. Waljee, A. Morris, and P. Higgins Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis Gut 55 2006 1575
11. O.H. Nielsen, B. Andreasson, S. Bondesen, and S. Jarnum Pregnancy in ulcerative colitis Scand J Gastroenterol 18 1983 735 742
12. O.H. Nielsen, B. Andreasson, S. Bondesen, O. Jacobsen, and S. Jarnum Pregnancy in Crohn's disease Scand J Gastroenterol 19 1984 724 732
13. F. Castiglione, S. Pignata, and F. Morace Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease Ital J Gastroenterol 28 1996 199 204
14. S. Kane, J. Kisiel, L. Shih, and S. Hanauer HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease Am J Gastroenterol 99 2004 1523 1526
15. F. Agret, J. Cosnes, and Z. Hassani Impact of pregnancy on the clinical activity of Crohn's disease Aliment Pharm Therap 21 2005 509 513
16. I. Christiaens, D.B. Zaragoza, L. Guilbert, S.A. Robertson, B.F. Mitchell, and D.M. Olson Inflammatory processes in preterm and term parturition J Reprod Immunol 79 2008 50 57
17. S. Beck, D. Wojdyla, and L. Say The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity Bull World Health Organ 88 2010 31 38
18. Mo Dimes PeriStats 2006 White Plains New York
19. C. Abraham, and J. Cho Interleukin-23/Th17 pathways and inflammatory bowel disease Inflamm Bowel Dis 15 2009 1090 1100
20. J. Dambacher, F. Beigel, and K. Zitzmann The role of the novel Th17 cytokine IL-26 in intestinal inflammation Gut 58 2009 1207 1217
21. M.I. Koenders, and W.B. Van Den Berg Translational Mini-Review Series on Th17 Cells: Are T helper 17 cells really pathogenic in autoimmunity? Clin Exp Immunol 159 2010 131 136
22. M.C. Kullberg, D. Jankovic, and C.G. Feng IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis J Exp Med 203 2006 2485 2494
23. S.C. Liang, X.Y. Tan, and D.P. Luxenberg Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides J Exp Med 203 2006 2271 2279
24. S.C. Higgins, A.G. Jarnicki, E.C. Lavelle, and K.H. Mills TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells J Immunol 177 2006 7980 7989
25. N.J. Wilson, K. Boniface, and J.R. Chan Development, cytokine profile and function of human interleukin 17ñproducing helper T cells Nat Immunol 8 2007 950 957
26. R. Nurieva, X.O. Yang, and G. Martinez Essential autocrine regulation by IL-21 in the generation of inflammatory T cells Nature 448 2007 480 483
27. C.L. Langrish, Y. Chen, and W.M. Blumenschein IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 2005 233 240
28. T. Kobayashi, S. Okamoto, and T. Hisamatsu IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease Gut 57 2008 1682 1689
29. J. Louten, K. Boniface, and R. De Waal Malefyt Development and function of T[H]17 cells in health and disease 2009 Elsevier New York
30. Z. Chen, C.M. Tato, L. Muul, A. Laurence, and J.J. O'Shea Distinct regulation of interleukin-17 in human T helper lymphocytes Arthritis Rheum 56 2007 2936 2946
31. M. Veldhoen, R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger TGF [beta] in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells Immunity 24 2006 179 189
32. L.A. Tesmer, S.K. Lundy, S. Sarkar, and D.A. Fox Th17 cells in human disease Immunol Rev 223 2008 87 113
33. L. Yang, D.E. Anderson, and C. Baecher-Allan IL-21 and TGF-beta; are required for differentiation of human TH17 cells Nature 454 7202 2008 350 352
34. P.R. Mangan, L.E. Harrington, and D.B. O'Quinn Transforming growth factor-beta induces development of the T(H)17 lineage Nature 441 2006 231 234
35. M. Baggiolini, B. Dewald, and B. Moser lnterleukin-8 and related chemotactic cytokines-CXC and CC chemokines J.D. Frank, Advances in immunology 1993 Academic Press San Diego, Calif 97 179
36. M. Laan, Z.-H. Cui, H. Hoshino, J. Lötvall, M. Sjöstrand, and D.C. Gruenert Neutrophil recruitment by human IL-17 Via C-X-C chemokine release in the airways J Immunol 162 1999 2347 2352
37. C. Chizzolini, R. Chicheportiche, and M. Alvarez Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion Blood 112 2008 3696 3703
38. M.A. Hoeve, N.D.L. Savage, and T. de Boer Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells Eur J Immunol 36 2006 661 670
39. I. Kryczek, S. Wei, and L.H. Vatan Cutting edge: Opposite effects of IL-1 and IL-2 on the regulation of IL-17(+) T cell pool IL-1 subverts IL-2-mediated suppression J Immunol 179 2007 1423 1426
40. L.E. Harrington, R.D. Hatton, and P.R. Mangan Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 2005 1123 1132
41. H. Park, Z.X. Li, and X.O. Yang A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6 2005 1133 1141
42. I. Kryczek, A.T. Bruce, and J.E. Gudjonsson Induction of IL-17(+) T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis J Immunol 181 2008 4733 4741
43. N. Manel, D. Unutmaz, and D.R. Littman The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat Nat Immunol 9 2008 641 649
44. E. Volpe, N. Servant, and R. Zollinger A critical function for transforming growth factor-, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses Nat Immunol 9 2008 650 657
45. K.M. Dhodapkar, S. Barbuto, and P. Matthews Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma Blood 112 2008 2878 2885
46. K. Boniface, W.M. Blumenschein, and K. Brovont-Porth Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage J Immunol 185 2010 679 687
47. I.I. Ivanov, L. Frutos Rde, and N. Manel Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine Cell Host Microbe 4 2008 337 349
48. K. Atarashi, J. Nishimura, and T. Shima ATP drives lamina propria T(H)17 cell differentiation Nature 455 2008 808 812
49. R.H. Duerr, K.D. Taylor, and S.R. Brant A genome-wide association study identifies IL23R as an inflammatory bowel disease gene Science 314 2006 1461 1463
50. M.C. Dubinsky, D. Wang, and Y. Picornell IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease Inflamm Bowel Dis 13 2007 511 515
51. D. Yen, J. Cheung, and H. Scheerens IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 J Clin Invest 116 2006 1310
52. C. Schmidt, T. Giese, and B. Ludwig Expression of interleukin 12 related cytokine transcripts in inflammatory bowel disease: elevated interleukin 23p19 and interleukin 27p28 in Crohn's disease but not in ulcerative colitis Inflamm Bowel Dis 11 2005 16 23
53. S. Fujino, A. Andoh, and S. Bamba Increased expression of interleukin 17 in inflammatory bowel disease Gut 52 2003 65 70
54. J. Seiderer, I. Elben, and J. Diegelmann Role of the novel Th17 cytokine IL 17F in inflammatory bowel disease (IBD): upregulated colonic IL 17F expression in active Crohn's disease and analysis of the IL17F p. His161Arg polymorphism in IBD Inflamm Bowel Dis 14 2008 437 445
55. P. Parronchi, P. Romagnani, and F. Annunziato Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease Am J Pathol 150 1997 823 832
56. J. Mudter, B. Weigmann, and B. Bartsch Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases Am J Gastroenterol 100 2005 64 72
57. M.F. Neurath, B. Weigmann, and S. Finotto The transcription factor T-bet regulates mucosal T Cell activation in experimental colitis and Crohn's disease J Exp Med 195 2002 1129 1143
58. W. Strober, I. Fuss, and P. Mannon The fundamental basis of inflammatory bowel disease J Clin Invest 117 2007 514
59. I.J. Fuss, M. Neurath, and M. Boirivant Disparate CD4(+) lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease - Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1996 1261 1270
60. G. Monteleone, L. Biancone, and R. Marasco Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells Gastroenterology 112 1997 1169 1178
61. D.C. Baumgart, and W.J. Sandborn Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 2007 1641 1657
62. W. Reinisch, D.W. Hommes, and G. Van Assche A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon antibody, in patients with moderate to severe Crohn's disease Gut 55 2006 1138
63. D.W. Hommes, T.L. Mikhajlova, and S. Stoinov Fontolizumab, a humanised anti-interferon γ antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease Gut 55 2006 1131 1137
64. P.J. Mannon, I.J. Fuss, and L. Mayer Anti-Interleukin-12 Antibody for Active Crohn's Disease N Engl J Med 351 2004 2069 2079
65. F. Heller, P. Florian, and C. Bojarski Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution Gastroenterology 129 2005 550 564
66. D. McGovern, and F. Powrie The IL23 axis plays a key role in the pathogenesis of IBD Gut 56 2007 1333 1336
67. A.N. Mathur, H.C. Chang, and D.G. Zisoulis T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype Blood 108 2006 1595 1601
68. N.M. Orsi, N. Gopichandran, U.V. Ekbote, and J.J. Walker Murine serum cytokines throughout the estrous cycle, pregnancy and post partum period Anim Reprod Sci 96 2006 54 65
69. M. Hampl, K. Friese, I. Pracht, W. Zieger, M. Weigel, and H. Gallati [Determination of cytokines and cytokine receptors in premature labor] Geburtshilfe Frauenheilkd 55 1995 483 489
70. J.E. Boyson, I. Aktan, D.A. Barkhuff, and A. Chant NKT cells at the maternal-fetal interface Immunol Invest 37 2008 565 582
71. J.R. Challis, C.J. Lockwood, L. Myatt, J.E. Norman, J.F. Strauss 3rd, and F. Petraglia Inflammation and pregnancy Reprod Sci 16 2009 206 215
72. J. Szekeres-Bartho, J. Wilczynski, P. Basta, and J. Kalinka Role of progesterone and progestin therapy in threatened abortion and preterm labour Front Biosci 13 2008 1981
73. R. Druckmann, and M.A. Druckmann Progesterone and the immunology of pregnancy J Steroid Biochem Mol Biol 97 2005 389 396
74. G. Chaouat The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 29 2007 95 113
75. M.I. de Moraes-Pinto, G.S. Vince, B.F. Flanagan, C.A. Hart, and P.M. Johnson Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes Immunology 90 1997 87 94
76. M.P. Piccinni, L. Beloni, C. Livi, E. Maggi, G. Scarselli, and S. Romagnani Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions Nat Med 4 1998 1020 1024
77. R. Raghupathy Th 1-type immunity is incompatible with successful pregnancy Immunol Today 18 1997 478 482
78. G. Chaouat, N. Ledee-Bataille, and S. Zourbas Cytokines, implantation and early abortion: re-examining the Th1/Th2 paradigm leads to question the single pathway, single therapy concept Am J Reprod Immunol 50 2003 177 186
79. M.D. Bates, S. Quenby, K. Takakuwa, P.M. Johnson, and G.S. Vince Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Hum Reprod 17 2002 2439 2444
80. G. Mor Inflammation and pregnancy: the role of toll-like receptors in trophoblast-immune interaction Ann NY Acad Sci 1127 2008 121 128
81. L. Arruvito, A. Billordo, M. Capucchio, M.E. Prada, and L. Fainboim IL-6 trans-signaling and the frequency of CD4+FOXP3+ cells in women with reproductive failure J Reprod Immunol 82 2009 158 165
82. C. Albanesi, A. Cavani, and G. Girolomoni IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha J Immunol 162 1999 494 502
83. B. Vanaudenaerde, L. Dupont, and W. Wuyts The role of interleukin-17 during acute rejection after lung transplantation Eur Respir J 27 2006 779
84. C.C. Loong, H.G. Hsieh, W.Y. Lui, A. Chen, and C.Y. Lin Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection J Pathol 197 2002 322 332
85. S. Yoshida, A. Haque, and T. Mizobuchi Anti Type V Collagen lymphocytes that express IL 17 and IL 23 induce rejection pathology in fresh and well healed lung transplants Am J Transpl 6 2006 724 735
86. D.F. Fiorentino, A. Zlotnik, and P. Vieira Il-10 Acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells J Immunol 146 1991 3444 3451
87. Q. He, T.T. Moore, and F.O. Eko Molecular basis for the potency of IL-10-deficient dendritic cells as a highly efficient APC system for activating Th1 response J Immunol 174 2005 4860 4869
88. S. Nakae, Y. Iwakura, H. Suto, and S.J. Galli Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17 J Leukoc Biol 81 2007 1258 1268
89. K. Hirota, M. Hashimoto, and H. Yoshitomi T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis J Exper Med 204 2007 41 47
90. E.A. Martinez-Garcia, B. Chavez-Robles, and P.E. Sanchez-Hernandez IL-17 increased in the third trimester in healthy women with term labor Am J Reprod Immunol 65 2011 99 103
91. A. Nakashima, M. Ito, S. Yoneda, A. Shiozaki, T. Hidaka, and S. Saito Circulating and decidual Th17 cell levels in healthy pregnancy Am J Reprod Immunol 63 2010 104 109
92. M.P. Piccinni, C. Scaletti, A. Vultaggio, E. Maggi, and S. Romagnani Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss J Reprod Immunol 52 2001 35 43
93. A. Cassinotti, S. Birindelli, and M. Clerici HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists Am J Gastroenterol 104 2009 195 217
94. S. Kovats, E. Main, C. Librach, M. Stubblebine, S. Fisher, and R. DeMars A class I antigen, HLA-G, expressed in human trophoblasts Science 248 1990 220 223
95. J.S. Hunt, P.J. Morales, J.L. Pace, A.T. Fazleabas, and D.K. Langat A commentary on gestational programming and functions of HLA-G in pregnancy Placenta 28 suppl 1 2007 S57 S63
96. J.S. Hunt Stranger in a strange land Immunol Rev 213 2006 36 47
97. P. Le Bouteiller, J. Tabiasco, and J. Parinaud Soluble HLA-G and embryo implantation: frequently asked questions Gynecol Obstet Inves 64 2007 134 137
98. E.D. Carosella, P. Moreau, J. LeMaoult, and N. Rouas-Freiss HLA-G: from biology to clinical benefits Trends Immunol 29 2008 125 132
99. E.D. Carosella, K.Y. HoWangYin, B. Favier, and J. LeMaoult HLA-G-dependent suppressor cells: Diverse by nature, function, and significance Hum Immunol 69 2008 700 707
100. C. Guillard, I. Zidi, C. Marcou, C. Menier, E.D. Carosella, and P. Moreau Role of HLA-G in innate immunity through direct activation of NF-κB in natural killer cells Mol Immunol 45 2008 419 427
101. L. Ferrero-Miliani, O.H. Nielsen, P.S. Andersen, and S.E. Girardin Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1 beta generation Clin Exp Immunol 147 2007 227 235
102. J.R. Challis, and S.J. Lye Parturition Oxf Rev Reprod Biol 8 1986 61 129
103. D.M. Olson The role of prostaglandins in the initiation of parturition Best Pract Res Clin Obstet Gynaecol 17 2003 717 730
104. M. Fukata, A.S. Vamadevan, and M.T. Abreu Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders Semin Immunol 21 2009 242 253
105. K.A. Smoak, J.J. Aloor, and J. Madenspacher Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation Cell Metab 11 2010 493 502
106. M.W. Covert, T.H. Leung, J.E. Gaston, and D. Baltimore Achieving stability of lipopolysaccharide-induced NF-κB activation Science 309 2005 1854 1857
107. S.K. Biswas, and V. Tergaonkar Myeloid differentiation factor 88-independent Toll-like receptor pathway: sustaining inflammation or promoting tolerance? Int J Biochem Cell Biol. 39 2007 1582 1592
108. D. Franchimont, S. Vermeire, and H. El Housni Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis Gut 53 2004 987 992
109. B.L. Browning, C. Huebner, and I. Petermann Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association Am J Gastroenterol 102 2007 2504 2512
110. A. Franke, D.P.B. McGovern, and J.C. Barrett Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci Nat Genet 42 2010 1118 1121
111. G.E. Hume, E.V. Fowler, and J. Doecke Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population Inflamm Bowel Dis 14 2008 585 590
112. M. Pierik, S. Joossens, and K. Van Steen Toll like receptor 1, 2, and 6 polymorphisms influence disease extension in inflammatory bowel diseases Inflamm Bowel Dis 12 2006 1 8
113. D.K. Podolsky, G. Gerken, A. Eyking, and E. Cario Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency Gastroenterology 137 2009 209 220
114. G. Melmed, L.S. Thomas, and N. Lee Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut J Immunol 170 2003 1406 1415
115. E. Cario, and D.K. Podolsky Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease Infect Immun 68 2000 7010 7017
116. M.T. Abreu, E.T. Arnold, and L.S. Thomas TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells J Biol Chem 277 2002 20431 20437
117. M. Suzuki, T. Hisamatsu, and D.K. Podolsky Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex Infect Immun 71 2003 3503
118. M. Hausmann, S. Kiessling, and S. Mestermann Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation Gastroenterology 122 2002 1987 2000
119. L. Frolova, P. Drastich, P. Rossmann, K. Klimesova, and H. Tlaskalova-Hogenova Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis J Histochem Cytochem 56 2008 267 274
120. M.T. Abreu, P. Vora, E. Faure, L.S. Thomas, E.T. Arnold, and M. Arditi Decreased expression of toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide J Immunol 167 2001 1609 1616
121. J.M. Otte, E. Cario, and D.K. Podolsky Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells Gastroenterology 126 2004 1054 1070
122. T. Jilling, D. Simon, and J. Lu The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis J Immunol 177 2006 3273 3282
123. R.D. Fusunyan, N.N. Nanthakumar, M.E. Baldeon, and W.A. Walker Evidence for an innate immune response in the immature human intestine: Toll-like receptors on fetal enterocytes Pediatr Res 49 2001 589 593
124. P.A. Ruiz, A. Shkoda, S.C. Kim, R.B. Sartor, and D. Haller IL-10 gene-deficient mice lack TGF-/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis J Immunol 174 2005 2990
125. G. Pedersen, L. Andresen, M.W. Matthiessen, J. Rask-Madsen, and J. Brynskov Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium Clin Exper Immunol 141 2005 298 306
126. D. Rachmilewitz, F. Karmeli, S. Shteingart, J. Lee, K. Takabayashi, and E. Raz Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis Inflamm Bowel Dis 12 2006 339 345
127. M.T. Abreu Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function Nat Rev Immunol 10 2010 131 144
128. A.T. Gewirtz, T.A. Navas, S. Lyons, P.J. Godowski, and J.L. Madara Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression J Immunol 167 2001 1882 1885
129. S.H. Rhee, E. Im, M. Riegler, E. Kokkotou, M. O'Brien, and C. Pothoulakis Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation Proc Natl Acad Sci U S A 102 2005 13610
130. M. Vijay-Kumar, H. Wu, R. Jones, G. Grant, B. Babbin, and T.P. King Flagellin suppresses epithelial apoptosis and limits disease during enteric infection Am J of Pathol 69 2006 1686 1700
131. Y. Yu, S. Nagai, H. Wu, A.S. Neish, S. Koyasu, and A.T. Gewirtz TLR5-mediated phosphoinositide 3-kinase activation negatively regulates flagellin-induced proinflammatory gene expression J Immunol 176 2006 6194
132. H. Zeng, H. Wu, and V. Sloane Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways Am J Physiol Gastrointest Liver Physiol 290 2006 G96
133. M. Fukata, K.S. Michelsen, and R. Eri Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis Am J Physiol Gastrointest Liver Physiol 288 2005 G1055 G1065
134. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis Cell 118 2004 229 241
135. M. Fukata, Y. Hernandez, and D. Conduah Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors Inflamm Bowel Dis 15 2009 997 1006
136. F. Rieder, M. Georgieva, and A. Schirbel Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts Inflamm Bowel Dis 16 2010 1505 1513
137. E. Cario, G. Gerken, and D.K. Podolsky Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function Gastroenterology 132 2007 1359 1374
138. M. Vijay-Kumar, H. Wu, and J. Aitken Activation of toll like receptor 3 protects against DSS induced acute colitis Inflamm Bowel Dis 13 2007 856 864
139. D. Rachmilewitz, F. Karmeli, and K. Takabayashi Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis Gastroenterology 122 2002 1428 1441
140. D. Rachmilewitz, K. Katakura, and F. Karmeli Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis 1 Gastroenterology 126 2004 520 528
141. K. Katakura, J. Lee, D. Rachmilewitz, G. Li, L. Eckmann, and E. Raz Toll-like receptor 9-induced type I IFN protects mice from experimental colitis J Clin Invest 115 2005 695 702
142. J. Lee, J.-H. Mo, and K. Katakura Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells Nat Cell Biol 8 2006 1327 1336
143. T. Mueller, T. Terada, I.M. Rosenberg, O. Shibolet, and D.K. Podolsky Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cells J Immunol 176 2006 5805 5814
144. M. Lotz, T. Konig, S. Menard, D. Guetle, C. Bogdan, and M.W. Hornef Cytokine-mediated control of lipopolysaccharide-induced activation of small intestinal epithelial cells Immunology 122 2007 306 315
145. D.A. Rao, K.J. Tracey, and J.S. Pober IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response J Immunol 179 2007 6536 6546
146. E.V. Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells Nat Immunol 8 2007 942 949
147. H.P. Torok, J. Glas, and I. Endres Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease Am J Gastroenterol 104 2009 1723 1733
148. M. Mitsunari, S. Yoshida, and T. Shoji Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E-2 via toll-like receptor 2 in human placental trophoblast cells J Reprod Immunol 72 2006 46 59
149. V.M. Abrahams, I. Visintin, P.B. Aldo, S. Guller, R. Romero, and G. Mor A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells J Immunol 175 2005 8096 8104
150. E.C.E. Beijar, C. Mallard, and T.L. Powell Expression and subcellular localization of TLR-4 in term and first trimester human placenta Placenta 27 2006 322 326
151. K. Koga, and G. Mor Review article: expression and function of Toll-like receptors at the maternal - fetal interface Reprod Sci 15 2008 231 242
152. V.M. Abrahams, P. Bole-Aldo, and Y.M. Kim Divergent trophoblast responses to bacterial products mediated by TLRs J Immunol 173 2004 4286 4296
153. T.M. Schaefer, K. Desouza, J.V. Fahey, K.W. Beagley, and C.R. Wira Toll like receptor (TLR) expression and TLR mediated cytokine/chemokine production by human uterine epithelial cells Immunology 112 2004 428 436
154. O. Takeuchi, K. Hoshino, and S. Akira Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection J Immunol 165 2000 5392
155. S.L. Young, T.D. Lyddon, R.L. Jorgenson, and M.L. Misfeldt Expression of Toll like receptors in human endometrial epithelial cells and cell lines Am J Reprod Immunol 52 2004 67 73
156. Thaxton JE, Nevers TA, Sharma S. TLR-mediated preterm birth in response to pathogenic agents. Infect Dis Obstet Gynecol. Epub 2010 Aug 23.
157. H.D. Watts, M.A. Krohn, S.L. Hillier, and D.A. Eschenbach The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor Obstet Gynecol 79 1992 351
158. R. Romero, M. Sirtori, and E. Oyarzun Infection and labor. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes Am J Obstet Gynecol 161 1989 817
159. R.L. Goldenberg, J.C. Hauth, and W.W. Andrews Intrauterine infection and preterm delivery N Engl J Med 342 2000 1500 1507
160. R.L. Goldenberg, J.F. Culhane, J.D. Iams, and R. Romero Epidemiology and causes of preterm birth Lancet 371 2008 75 84
161. T.G. Krediet, S.P. Wiertsema, and M.J. Vossers Toll-like receptor 2 polymorphism is associated with preterm birth Pediatr Res 62 2007 474 476
162. G. Rey, F. Skowronek, J. Alciaturi, J. Alonso, B. Bertoni, and R. Sapiro Toll receptor 4 Asp299Gly polymorphism and its association with preterm birth and premature rupture of membranes in a South American population Mol Hum Reprod 14 2008 555
163. E. Lorenz, M. Hallman, R. Marttila, R. Haataja, and D.A. Schwartz Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population Pediatr Res 52 2002 373 376
164. J.P. Hugot, M. Chamaillard, and H. Zouali Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599 603
165. Y. Ogura, D.K. Bonen, and N. Inohara A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 2001 603 606
166. D.P. McGovern, P. Hysi, and T. Ahmad Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease Hum Mol Genet 14 2005 1245 1250
167. G. Chen, M.H. Shaw, Y.G. Kim, and G. Nunez NOD-like receptors: role in innate immunity and inflammatory disease Annu Rev Pathol 4 2009 365 398
168. C. Huebner, L.R. Ferguson, and D.Y. Han Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand caucasian population: a case-control study BMC Res Notes 2 2009 52
169. N. Inohara, Y. Ogura, and A. Fontalba Host recognition of bacterial muramyl dipeptide mediated through NOD2 J Biol Chem 278 2003 5509 5512
170. J.H. Fritz, R.L. Ferrero, D.J. Philpott, and S.E. Girardin Nod-like proteins in immunity, inflammation and disease Nat Immunol 7 2006 1250 1257
171. S.E. Girardin, I.G. Boneca, and L.A.M. Carneiro Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan Science 300 2003 1584 1587
172. M. Chamaillard, M. Hashimoto, and Y. Horie An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid Nat Immunol 4 2003 702 707
173. T.D. Kanneganti, M. Lamkanfi, and Y.G. Kim Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling Immunity 26 2007 433 443
174. Inohara, Chamaillard, C. McDonald, and G. Nunez NOD-LRR proteins: role in host-microbial interactions and inflammatory disease Annu Rev Biochem 74 2005 355 383
175. M. Chamaillard, D. Philpott, and S.E. Girardin Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases Proc Natl Acad Sci U S A 100 2003 3455 3460
176. M. Windheim, C. Lang, M. Peggie, L.A. Plater, and P. Cohen Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide Biochem J 404 Pt 2 2007 179
177. J.H. Park, Y.G. Kim, and C. McDonald RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs J Immunol 178 2007 2380 2386
178. J. Bertin, W.-J. Nir, and C.M. Fischer Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB J Biol Chem 274 1999 12955 12958
179. N. Inohara, T. Koseki, and L. del Peso Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB J Biol Chem 274 1999 14560 14567
180. M.J. Costello, S.K. Joyce, and V.M. Abrahams NOD protein expression and function in first trimester trophoblast cells Am J Reprod Immunol 57 2007 67 80
181. M.J. Mulla, A.G. Yu, I. Cardenas, S. Guller, B. Panda, and V.M. Abrahams Regulation of Nod1 and Nod2 in first trimester trophoblast cells Am J Reprod Immunol 61 2009 294 302
182. D. Baud, L. Regan, and G. Greub Emerging role of chlamydia and chlamydia-like organisms in adverse pregnancy outcomes Curr Opin Infect Dis 21 2008 70 76
183. A.A. Azenabor, P. Kennedy, and S. Balistreri Chlamydia trachomatis infection of human trophoblast alters estrogen and progesterone biosynthesis: an insight into role of infection in pregnancy sequelae Int J Med Sci 4 2007 223 231
184. J.M. Rhodes The role of Escherichia coli in inflammatory bowel disease Gut 56 2007 610
185. C.D. Packey, and R.B. Sartor Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases Curr Opin Infect Dis 22 2009 292 301
186. Y. Filipovich, S.J. Lu, S. Akira, and E. Hirsch The adaptor protein MyD88 is essential for E coli-induced preterm delivery in mice Am J Obstet Gynecol 200 2009 93.e1 93.e8
187. M.A. Krohn, S.S. Thwin, L.K. Rabe, Z. Brown, and S.L. Hillier Vaginal colonization by Escherichia coli as a risk factor for very low birth weight delivery and other perinatal complications J Infect Dis 175 1997 606
188. D. Slater, W. Dennes, R. Sawdy, V. Allport, and P. Bennett Expression of cyclo-oxygenase types-1 and-2 in human fetal membranes throughout pregnancy J Mol Endocrinol 22 1999 125
189. C. Xiao, J. Liu, J. Sirois, and A. Goff Regulation of cyclooxygenase-2 and prostaglandin F synthase gene expression by steroid hormones and interferon- in bovine endometrial cells Endocrinology 139 1998 2293
190. I.I. Singer, D.W. Kawka, S. Schloemann, T. Tessner, T. Riehl, and W.F. Stenson Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease Gastroenterology 115 1998 297 306
191. M.H.L.P. Souza, O.M. de Lima, S.R. Zamuner, S. Fiorucci, and J.L. Wallace Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis Am J Physiol Gastrointest Liver Physiol 285 2003 G54
192. H. Fujino, W. Xu, and J.W. Regan Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases J Biol Chem. 278 2003 12151 12156
193. J.L. Goulet, A.J. Pace, and M.L. Key E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation J Immunol 173 2004 1321 1326
194. T. Hoshino, S. Tsutsumi, W. Tomisato, H.J. Hwang, T. Tsuchiya, and T. Mizushima Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation J Biol Chem 278 2003 12752 12758
195. R.R. Joseph, E. Yazer, Y. Hanakawa, and A.W. Stadnyk Prostaglandins and activation of AC/cAMP prevents anoikis in IEC-18 Apoptosis 10 2005 1221 1233
196. M. Murakami, and I. Kudo Prostaglandin E synthase: a novel drug target for inflammation and cancer Curr Pharm Des 12 2006 943 954
197. S.G. Harris, J. Padilla, L. Koumas, D. Ray, and R.P. Phipps Prostaglandins as modulators of immunity Trends Immunol 23 2002 144 150
198. T. Khayrullina, J.-H. Yen, H. Jing, and D. Ganea In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells J Immunol 181 2008 721 735
199. K. Boniface, K.S. Bak-Jensen, and Y. Li Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling J Exp Med 206 2009 535 548
200. G. Napolitani, E.V. Acosta-Rodriguez, A. Lanzavecchia, and F. Sallusto Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-γ production by memory CD4+ T cells Eur J Immunol 39 2009 1301 1312
201. M. Fukata, A. Chen, and A. Klepper Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine Gastroenterology 131 2006 862 877
202. C.A. Anderson, G. Boucher, and C.W. Lees Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 Nat Genet 43 2011 246 252
203. S.L. Pull, J.M. Doherty, J.C. Mills, J.I. Gordon, and T.S. Stappenbeck Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury Proc Natl Acad Sci U S A 102 2005 99
204. S.L. Brown, T.E. Riehl, and M.R. Walker Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury J Clin Invest 117 2007 258 269
205. M.N. Ajuebor, A. Singh, and J.L. Wallace Cyclooxygenase-2-derived prostaglandin D-2 is an early anti-inflammatory signal in experimental colitis Am J Physiol Gastrointest Liver Physiol 279 2000 G238 G244
206. R. Rajakariar, M. Hilliard, and T. Lawrence Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxy 12ñ14 PGJ2 Proc Natl Acad Sci U S A 104 2007 20979
207. L. Vong, J.G.P. Ferraz, R. Panaccione, P.L. Beck, and J.L. Wallace A pro-resolution mediator, prostaglandin D2, is specifically up-regulated in individuals in long-term remission from ulcerative colitis Proc Natl Acad Sci U S A 107 2010 12023
208. R. Romero, H. Munoz, and R. Gomez Increase in prostaglandin bioavailability precedes the onset of human parturition Prostaglandins Leukot Essent Fatty Acids 54 1996 187 191
209. J.A. Keelan, T. Sato, and M.D. Mitchell Regulation of interleukin (IL)-6 and IL-8 production in an amnion-derived cell line by cytokines, growth factors, glucocorticoids, and phorbol esters Am J Reprod Immunol 38 1997 272 278
210. M. Fukushima Prostaglandin J2-anti-tumour and anti-viral activities and the mechanisms involved Eicosanoids 3 1990 189 199
211. M. Fukushima Biological activities and mechanisms of action of PGJ2 and related compounds: an update Prostaglandins Leukot Essent Fatty Acids 47 1992 1 12
212. K.W. Marvin, J.A. Keelan, M.A. Coleman, L.M. McCowan, R.L. Zhou, and M.D. Mitchell Intercellular adhesion molecule-1 (ICAM-1) in cervicovaginal fluid of women presenting with preterm labor: predictive value for preterm delivery Am J Reprod Immunol 43 2000 264 271
213. J.A. Keelan, T.A. Sato, K.W. Marvin, J. Lander, R.S. Gilmour, and M.D. Mitchell 15-Deoxy-Delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells Biochem Biophys Res Commun 262 1999 579 585
214. W.E. Ackerman 4th, X.L. Zhang, B.H. Rovin, and D.A. Kniss Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells Biol Reprod 73 2005 527 535
215. J.A. Keelan, M. Blumenstein, R.J.A. Helliwell, T.A. Sato, K.W. Marvin, and M.D. Mitchell Cytokines, prostaglandins and parturition-a review Placenta 24 Suppl A 2003 S33 S46
216. C. Wahl, S. Liptay, G. Adler, and R.M. Schmid Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B J Clin Invest 101 1998 1163
217. L.J. Egan, D.C. Mays, and C.J. Huntoon Inhibition of interleukin-1- stimulated NF-κB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity J Biol Chem 274 1999 26448 26453
218. P.J. Barnes, and I.M. Adcock Glucocorticoid resistance in inflammatory diseases Lancet 373 2009 1905 1917
219. N. Auphan, J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin Immunosuppression by glucocorticoids: inhibition of NF- B activity through induction of I B synthesis Science 270 1995 286
220. F. Hirata, M.L. Stracke, and E. Schiffmann Regulation of prostaglandin formation by glucocorticoids and their second messenger, lipocortins J Steroid Biochem 27 1987 1053 1056
221. H. Arndt, K. Palitzsch, M. Grisham, and D. Granger Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules Gastroenterology 106 1994 1271
222. L. Shakir, A. Javeed, M. Ashraf, and A. Riaz Metronidazole and the immune system Pharmazie 66 2011 393 398
223. C. Breynaert, M. Ferrante, and H. Fidder Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study Am J Gastroenterol 106 2011 778 785
224. S. Meyer, N.G. Kohler, and A. Joly Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-[kappa] B activation FEBS Lett 413 1997 354 358
225. S.L. Schreiber, and G.R. Crabtree The mechanism of action of cyclosporin A and FK506 Immunol Today 13 1992 136 142
226. C.Y. Wu, C. Fargeas, T. Nakajima, and G. Delespesse Glucocorticoids suppress the production of interleukin 4 by human lymphocytes Eur J Immunol 21 1991 2645 2647
227. W. Almawi, M. Lipman, A. Stevens, B. Zanker, E. Hadro, and T. Strom Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma J Immunol 146 1991 3523
228. U. Mahadevan Fertility and pregnancy in the patient with inflammatory bowel disease Gut 55 2006 1198 1206
229. L. Park Wyllie, P. Mazzotta, and A. Pastuszak Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta analysis of epidemiological studies Teratology 62 2000 385 392
230. V.T. Armenti, M.J. Moritz, E.H. Cardonick, and J.M. Davison Immunosuppression in pregnancy: choices for infant and maternal health Drugs 62 2002 2361 2375
231. C. Gur, O. Diav-Citrin, S. Shechtman, J. Arnon, and A. Ornoy Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study Reprod Toxicol 18 2004 93 101
232. J.R. Challis, and S.K. Smith Fetal endocrine signals and preterm labor Biol Neonate 79 2001 163 167
233. L. Myatt, and K. Sun Role of fetal membranes in signaling of fetal maturation and parturition Int J Dev Biol 54 2010 545 553
234. P.W. Nathanielsz, D.A. Giussani, and W.X. Wu Stimulation of the switch in myometrial activity from contractures to contractions in the pregnant sheep and nonhuman primate Equine Vet J Suppl 24 1997 83 88
235. M. Shams, M. Kilby, and D. Somerset 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction Hum Reprod 13 1998 799
236. V. Murphy, R. Fittock, P. Zarzycki, M. Delahunty, R. Smith, and V.L. Clifton Metabolism of synthetic steroids by the human placenta Placenta 28 2007 39 46
237. C. Wibaux, I. Andrei, and J. Paccou Pregnancy during TNF [alpha] antagonist therapy: beware the rifampin-oral contraceptive interaction. Report of two cases Joint Bone Spine 77 2010 268 270
238. J.M. Berthelot, M. De Bandt, and P. Goupille Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature Joint Bone Spine 76 2009 28 34
239. S.M.M. Verstappen, Y. King, K.D. Watson, D.P.M. Symmons, and K.L. Hyrich Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register Ann Rheum Dis 70 2011 823
240. S. Ashkar, G.F. Weber, and V. Panoutsakopoulou Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity Science 287 2000 860 864
241. T.E. Cawston Proteinases and inhibitors Br Med Bull 51 1995 385 401
242. T. Hayashi, K. Matsuoka, M. Saitoh, S. Takeda, and M. Kimura Influence of alpha-tumor necrosis factor and beta-interleukin-1 on production of angiogenetic factors and thymidine phosphorylase activity in immortalized human decidual fibroblasts in vitro J Obstet Gynaecol Res 32 2006 15 22
243. D.F. Lewis, B.J. Canzoneri, and Y. Wang Maternal circulating TNF-alpha levels are highly correlated with IL-10 levels, but not IL-6 and IL-8 levels, in women with pre-eclampsia Am J Reprod Immunol 62 2009 269 274
244. P. Valtonen, K. Punnonen, and H. Saarelainen Maternal serum ADMA is not associated with proinflammatory cytokines or C-reactive protein during normal pregnancy Cytokine 46 2009 216 221
245. A.E. Curry, I. Vogel, and C. Drews Mid-pregnancy maternal plasma levels of interleukin 2, 6, and 12, tumor necrosis factor-alpha, interferon-gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery Acta Obstet Gynecol Scand 86 2007 1103 1110
246. A.E. Curry, I. Vogel, and K. Skogstrand Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors J Reprod Immunol 77 2008 152 160
247. J.P. Gisbert Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast feeding Inflamm Bowel Dis 16 2010 881 895
248. J. Branche, A. Cortot, and A. Bourreille Cyclosporine treatment of steroid refractory ulcerative colitis during pregnancy Inflamm Bowel Dis 15 2009 1044 1048
249. C. Randak, T. Brabletz, M. Hergenröther, I. Sobotta, and E. Serfling Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer EMBO J 9 1990 2529
250. E.A. Emmel, C.L. Verweij, D.B. Durand, K.M. Higgins, E. Lacy, and G.R. Crabtree Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation Science 246 1989 1617
251. L. Rostaing, O. Puyoo, and J. Tkaczuk Differences in type 1 and type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients Clin Transpl 13 1999 400 409
252. B.D. Maes, and Y.F.C. Vanrenterghem Cyclosporine: advantages versus disadvantages vis-à-vis tacrolimus Transpl Proc 36 Suppl 1 2004 S40 S49
253. T. Kuzuya, T. Kobayashi, and A. Katayama Evaluation of interleukin-2 mRNA in whole blood as a parameter for monitoring cyclosporine pharmacodynamics Biol Pharm Bull 32 2009 604 608
254. B. Bar Oz, R. Hackman, T. Einarson, and G. Koren Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis Transplantation 71 2001 1051
255. A. Kainz, I. Harabacz, I.S. Cowlrick, S.D. Gadgi, and D. Hagiwara Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus Transplantation 70 2000 1718 1721